We have a dual business structure, bio division with our stem cell technology at the core and medical device division with medical imaging technology and products at the core. Currently, the medical device division provide us with continuous revenue stream and income by selling and servicing our MRI's and bone mineral density meter or BMD's. Stemlab has been fully dedicated to the successful development and commercialization of 1,5T Superconductive MRI, 0.35T Open MRI with the new generation of the Bone Mineral Densitometry. StemLab will continue with its best effort in development of better clinical applications with mission to be the leader in diagnostic quality, after service and cost competitiveness. Stemlab is defined as Global Medical Marketing Company registered in Seoul, Korea.